Tara Carmack

709 citations
9 papers · 501 · 1 hit paper · h-index 6

Impact in

    • Systemic Lupus Erythematosus Research
    • Rheumatoid Arthritis Research and Therapies
    • T-cell and B-cell Immunology
    • Atherosclerosis and Cardiovascular Diseases

Papers in

    • Rheumatoid Arthritis Research and Therapies 4
    • Systemic Lupus Erythematosus Research 4
    • Autoimmune and Inflammatory Disorders Research 4

Tara Carmack

8 papers receiving 494 citations

Tara Carmack's Hit Papers

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial 2018 · 356 citations
3560+2+5Years since publication100200300

Peers

Tara Carmack
Comparison fields: 5 of 59
  • Rheumatology 381
  • Immunology 201
  • Hematology 89
  • Genetics 68
  • Oncology 141
Replace Lina-Marcela Díaz-Gallo with:
Lina-Marcela Díaz-Gallo Sweden
María López‐Lasanta Spain
Sandra Goss United States
Maria Juárez United Kingdom
Evripidis Kaltsonoudis Greece
Francesca Trentin Italy
Serghei Popa Moldova
Magdalena Szmyrka−Kaczmarek Poland
Sarah Fleischer Germany
Florence Casset‐Semanaz Switzerland
Tara Carmack relative to Lina-Marcela Díaz-Gallo Sweden Lina-Marcela Díaz-Gallo's profile →
Citations per field
00.5×3.6×
Lina-Marcela Díaz-Gallo · 1×
Citations per year

Countries citing papers authored by Tara Carmack

Since Specialization
Citations

This map shows the geographic impact of Tara Carmack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Carmack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Carmack more than expected).

Fields of papers citing papers by Tara Carmack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Carmack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Carmack. The network helps show where Tara Carmack may publish in the future.

Co-authors

The 25 scholars most cited alongside Tara Carmack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tara Carmack Line = papers co-authored together Tara Carmack links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
2018356
2 201751
3 201845
4 202127
5 20229
6 20176
7 20165
8 20182
9 20210

About Tara Carmack

Tara Carmack is a scholar working on Rheumatology, Hematology, Genetics, Oncology and Cellular and Molecular Neuroscience, having authored 9 papers that have together received 501 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Systemic Lupus Erythematosus Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Attention Deficit Hyperactivity Disorder (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper) and Obsessive-Compulsive Spectrum Disorders (1 paper). The work is most often cited by research in Rheumatology (381 citations), Immunology (201 citations), Hematology (89 citations), Genetics (68 citations) and Oncology (141 citations). Tara Carmack has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Amy M. DeLozier, Ian N Bruce, Yoshiya Tanaka, Elisa Gómez, Kenneth Kalunian, Marta Mosca, Maria Silk, Matthew D. Linnik, Robert W. Hoffman and Michelle Petri. Their work appears in journals such as Annals of the Rheumatic Diseases, Seizure, Neurology, Arthritis Research & Therapy and Expert Review of Neurotherapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact